CORPORATE UPDATE ON HUMAN UNITEC INTERNATIONAL, INC. (HMNU)
May 18 2021 - 11:15AM
InvestorsHub NewsWire
![Human Unitec International](https://investorshub.advfn.com/uimage/uploads/2021/5/18/Aspose.Words.05991da8-d225-46fa-92fb-bd37d0bd2aed.001.jpeg)
CORPORATE UPDATE
ON HUMAN UNITEC INTERNATIONAL, INC.
(HMNU)
Boston, MA -- May 18, 2021 -- InvestorsHub
NewsWire -- Human Unitec International, Inc., (OTC
Pink: HMNU) ("HMNU"), announces a strategic joint venture
distribution and marketing agreement with Periso, CH, "PERISO",
https://periso.ch/, a Swiss based
company since 1962.
The terms of the agreement require HMNU to
contribute the first financial of Four Million Five Hundred
Thousand Dollars, ($4,500,000), on or before June 30,
2021.
HMNU President, Fabrizio Bosticco, states: "This
agreement provides for an important participation of Periso with
our Group for the further integration and development of the MSK
Medical division. Periso provides innovative hi-tech medical
technology that use AI in order to improve the performance and
efficiency of Radiofrequency signals applied to treat brain
pathology like Alzheimer and Parkinson and Dementia. The
innovative technology is under patenting process. The WHO estimate
Worldwide, around 50 million people have dementia, and there are
nearly 10 million new cases every year. The duration of treatments
is 25 minutes and is painless with small side effect. The special
software support advanced business model like franchising or pay
per use or any other remote based payment method. Periso in
collaboration with HMNU planned to open a USA and Canada branches
and the upstate New York new HMNU's upcoming
faculty."
About Human Unitec International,
Inc.,
Human Unitec International, Inc., is a Project
Finance, Management & Development for Sustainability, Medical,
Wellness, and Green Energy and listed on the US OTC Market
(OTC
Pink: HMNU).
Forward-Looking
Statements
This document contains
certain forward-looking statements with respect to the financial
condition, results of operations and business of Human Unitec
International Inc., (HMNU), a startup company, and certain of the
plans and objectives of HMNU with respect to these items. Examples
of forward-looking statements include statements made about our
strategy, estimates of sales growth, future EBITA and future
developments in our organic business. Forward-looking statements
can be identified generally as those containing words such as
"anticipates", "assumes", "believes", "estimates", "expects",
"should", "will", "will likely result", "forecast", "outlook",
"projects", "may" or similar expressions. By their nature,
forward-looking statements involve risk and uncertainty because
they relate to future events and circumstances and there are many
factors that could cause actual results and developments to differ
materially from those expressed or implied by these forward-looking
statements.
These factors include,
but are not limited to, domestic and global economic and business
conditions, the successful implementation of our strategy and our
ability to realize the benefits of this strategy, our ability to
develop and market new products, changes in legislation, legal
claims, changes in exchange and interest rates, changes in tax
rates, pension costs and actuarial assumptions, raw materials and
employee costs, our ability to identify and complete successful
acquisitions and to integrate those acquisitions into our business,
our ability to successfully exit certain businesses or restructure
our operations, the rate of technological changes, political,
economic and other developments in countries where HMNU operates,
industry consolidation and competition. As a result, HMNU actual
future results may differ materially from the plans, goals and
expectations set forth in such forward-looking
statements.
Human Unitec International
Inc.
6, Liberty Square
suite 2328
Boston MA
02109 USA
Tel.+1.917.8219585
hmnuusa@gmail.com
Hman Unitec (PK) (USOTC:HMNU)
Historical Stock Chart
From Jan 2025 to Feb 2025
Hman Unitec (PK) (USOTC:HMNU)
Historical Stock Chart
From Feb 2024 to Feb 2025